James Fordyce

James W.
Fordyce is the founder of Critical Biologics Corp.
(founded in 2006) and Lotus Tissue Repair, Inc. (founded in 2011).
He holds the title of Director at Critical Biologics Corp.
and is the Chief Financial Officer & Director at Lotus Tissue Repair, Inc. in 2011.
Mr. Fordyce is also the founder of Chromaderm, Inc., FIBRX Derm, Inc...
Mr. Fordyce's current job(s) include being the Chairman at Albert & Mary Lasker Foundation, Director at VelQuest Corp.
since 2000, and Managing Partner at MEDNA Partners LLC since 2001.
Mr. Fordyce's former job(s) include being an Independent Director at Dyax Corp.
from 2011 to 2016, Director at Ore Pharmaceuticals, Inc., Director at Ore Holdings, Inc. from 2009 to 2010, and an Advisor at Darwin Ventures LLC.
Mr. Fordyce's education history includes an MBA from Harvard University in 1970, an undergraduate degree from the University of Pennsylvania in 1964, and an undergraduate degree from Magdalen College School Oxford Ltd in 1967.